Evaluation of the immutopics human FGF-23 (C-term) ELISA kit

被引：0
|
作者：
Preissner, C. M. [1 ]
Feighner, D. S. [1 ]
Singh, R. J. [1 ]
Grebe, S. K. [1 ]
机构：
[1] Mayo Fdn, Rochester, MN USA
来源：
CLINICAL CHEMISTRY | 2006年 / 52卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
E32
引用
收藏
页码：A174 / A174
页数：1
相关论文
共 50 条
  • [41] 替诺福韦酯治疗对慢性乙型肝炎患者血清FGF-23、β2-MG、Cys-C及RBP水平的影响
    陈勇华
    曹群奋
    洪琼怿
    王树民
    中国临床药理学与治疗学, 2017, 22 (07) : 799 - 804
  • [42] Evaluation of human pancreatic elastase-1 quantification in faeces extracted with a conventional method (weighing) and with the CALEX® Cap using the ScheBo® ELISA-KIT
    Pomazanovs, A.
    Roesel, A.
    Hartung, H.
    Niederberger, C.
    Mauerer, R.
    CLINICA CHIMICA ACTA, 2019, 493 : S362 - S362
  • [43] Kit ligand and c-kit are expressed during early human ovarian follicular development and their interaction is required for the survival of follicles in long-term culture.
    Carlsson, IB
    Laitinen, MPE
    Scott, JE
    Louhio, H
    Velentzis, L
    Tuuri, T
    Aaltonen, J
    Ritvos, O
    Winston, RML
    Hovatta, O
    JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2005, 12 (02) : 175A - 175A
  • [44] Pharmacokinetics (PK) and Pharmacodynamics (PD) of a Human Monoclonal Anti-FGF23 Antibody (KRN23) in a Long-Term Extension Study of Adults with X-linked Hypophosphatemia (XLH)
    Zhang, Xiaoping
    Imel, Erik
    Ruppe, Mary
    Weber, Thomas
    Klausner, Mark A.
    Gumbhir-Shah, Kavita
    Ito, Takahiro
    Vergeire, Maria
    Humphrey, Jeffrey S.
    Glorieux, Francis
    Portale, Anthony
    Insogna, Karl
    Peacock, Munro
    Carpenter, Thomas
    JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S483 - S483
  • [45] Biomarker evaluation of a c-KIT/KDR inhibitor (OSI-930) in human, rat and non-human primate PBMCs.
    Biesecker, G
    Li, Y
    Logan, T
    Hart, K
    Sennello, G
    Tomkinson, B
    Richardson, F
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9073S - 9073S
  • [46] QUANTITATIVE-EVALUATION OF THE TERMINAL C5B-9 COMPLEMENT COMPLEX BY ELISA IN HUMAN ATHEROSCLEROTIC ARTERIES
    NICULESCU, F
    HUGO, F
    RUS, HG
    VLAICU, R
    BHAKDI, S
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1987, 69 (02): : 477 - 483
  • [47] Development and evaluation of the recombinant BP26 protein-based C-ELISA for human brucellosis diagnosis
    Xie, Yujia
    Lin, Shaoqing
    Guo, Liping
    Qi, Xinru
    Zhao, Shiqi
    Pei, Qichuan
    Chen, Yixiao
    Wu, Qi
    Wang, Yun
    Yao, Meixue
    Yin, Dehui
    FRONTIERS IN MICROBIOLOGY, 2025, 15
  • [48] MODEL-BASED EVALUATION OF THE EFFICACY AND SAFETY OF BUROSUMAB, A FULLY HUMAN ANTI-FGF23 MONOCLONAL ANTIBODY, IN ADOLESCENT X-LINKED HYPOPHOSPHATEMIA (XLH)
    Shi, J.
    Gosselin, N. H.
    Chen, C.
    Wang, R.
    San Martin, J.
    VALUE IN HEALTH, 2018, 21 : S246 - S246
  • [49] Effect of weekly high-dose vitamin D3 supplementation on the association between circulatory FGF-23 and A1c levels in people with vitamin D deficiency: A randomized controlled 10-week follow-up trial
    Alimam, Sara M.
    Alhmoud, Jehad F.
    Khader, Heba A.
    Alsayed, Ahmad R.
    Abusamak, Mohammad
    Mohammad, Beisan A.
    Mosleh, Ibrahim
    Abu Khadrah, Khaled
    Aljaberi, Ahmad
    Habash, Maha
    Hasoun, Luai
    Abu-Samak, Mahmoud S.
    PHARMACY PRACTICE-GRANADA, 2024, 22 (02): : 1 - 8
  • [50] EXPANSION OF HEMATOPOIETIC ACTIVITY IN LONG-TERM CULTURE OF HUMAN BONE-MARROW BY C-KIT LIGAND (STEM-CELL FACTOR)
    FIRKIN, F
    DUNLOP, J
    BERTONCELLO, I
    GROWTH FACTORS, 1993, 8 (02) : 135 - 140
12345